We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures.
- Authors
Ernst, A; Campos, B; Meier, J; Devens, F; Liesenberg, F; Wolter, M; Reifenberger, G; Herold-Mende, C; Lichter, P; Radlwimmer, B
- Abstract
All-trans retinoic acid is a potent promoter of cellular differentiation processes, which is used in cancer therapy. Glioblastoma spheroid cultures are enriched in tumor-initiating cells, and provide a model to test new treatment options in vitro. We investigated the molecular mechanisms of response to exposure to differentiation-promoting conditions in such cultures. Microarray analyses of five independent cultures showed that after induction of differentiation, inhibitors of transforming growth factor-beta/bone morphogenetic protein, Wnt/beta-catenin and IGF signaling were upregulated, whereas expression of several microRNAs decreased, particularly that of the miR-17-92 cluster. In primary astrocytic gliomas (n=82), expression of several members of miR-17-92 was significantly higher relative to those of normal brain (n=8) and significantly increased with tumor grade progression (P<0.05). A high-level amplification of the miR-17-92 locus was detected in one glioblastoma specimen. Transfection of inhibitors of miR-17-92 induced increased apoptosis and decreased cell proliferation in glioblastoma spheroids. Mir-17-92 inhibition was also associated with increased messenger RNA (mRNA) and/or protein expression of CDKN1A, E2F1, PTEN and CTGF. The CTGF gene was shown to be a target of miR-17-92 in glioblastoma spheroids by luciferase reporter assays. Our results suggest that miR-17-92 and its target CTGF mediate effects of differentiation-promoting treatment on glioblastoma cells through multiple regulatory pathways.
- Publication
Oncogene, 2010, Vol 29, Issue 23, p3411
- ISSN
1476-5594
- Publication type
Journal Article
- DOI
10.1038/onc.2010.83